NO991733L - FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering - Google Patents

FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Info

Publication number
NO991733L
NO991733L NO991733A NO991733A NO991733L NO 991733 L NO991733 L NO 991733L NO 991733 A NO991733 A NO 991733A NO 991733 A NO991733 A NO 991733A NO 991733 L NO991733 L NO 991733L
Authority
NO
Norway
Prior art keywords
preparation
igm
intravenous administration
immunoglobulin
protease
Prior art date
Application number
NO991733A
Other languages
English (en)
Norwegian (no)
Other versions
NO991733D0 (no
Inventor
Markus Rentsch
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of NO991733D0 publication Critical patent/NO991733D0/no
Publication of NO991733L publication Critical patent/NO991733L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO991733A 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering NO991733L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (fr) 1996-10-14 1996-10-14 Procédé de préparation d'un médicament contenant de l'IgM administrable par voie intraveineuse
PCT/CH1997/000388 WO1998016558A1 (fr) 1996-10-14 1997-10-14 PROCEDE DE PRODUCTION D'UNE PREPARATION D'IgM POUR UNE ADMINISTRATION INTRAVEINEUSE

Publications (2)

Publication Number Publication Date
NO991733D0 NO991733D0 (no) 1999-04-13
NO991733L true NO991733L (no) 1999-06-11

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991733A NO991733L (no) 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Country Status (19)

Country Link
US (1) US6136312A (fr)
EP (1) EP0835880A1 (fr)
JP (1) JP2001504092A (fr)
KR (1) KR20000048826A (fr)
CN (1) CN1233258A (fr)
AU (1) AU725134B2 (fr)
BR (1) BR9712306A (fr)
CA (1) CA2266848A1 (fr)
CZ (1) CZ125599A3 (fr)
HU (1) HUP0001069A3 (fr)
ID (1) ID21364A (fr)
IL (1) IL129383A0 (fr)
NO (1) NO991733L (fr)
NZ (1) NZ334885A (fr)
PL (1) PL332774A1 (fr)
RU (1) RU2191032C2 (fr)
SI (1) SI9720063A (fr)
SK (1) SK46699A3 (fr)
WO (1) WO1998016558A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
CA2532966C (fr) * 2003-07-15 2012-12-04 Chugai Seiyaku Kabushiki Kaisha Production d'igm par des cellules transformees et methodes de quantification de cette production
EP1686137A4 (fr) 2003-10-09 2009-10-28 Chugai Pharmaceutical Co Ltd Methode de stabilisation de solution proteinique
ATE518888T1 (de) * 2003-10-09 2011-08-15 Chugai Pharmaceutical Co Ltd Stabilisierte lösung mit hoher igm-konzentration
PT1981540E (pt) * 2006-01-30 2013-05-07 Grifols Therapeutics Inc Método de tratamento e profilaxia de doenças relacionadas com a deposição de amilóides utilizando igm
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
KR20110017383A (ko) * 2008-05-12 2011-02-21 스트록스 바이오파마슈티컬스, 엘엘씨 황색 포도상구균-특이적 항체 제제
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
JP6166000B1 (ja) 2014-06-03 2017-07-19 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染症を治療および予防するための組成物および方法
EP4178978A1 (fr) * 2020-07-10 2023-05-17 Grifols Worldwide Operations Limited Procédé d'obtention d'une composition comprenant une immunoglobuline m dérivée du plasma humain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927112C1 (fr) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate

Also Published As

Publication number Publication date
JP2001504092A (ja) 2001-03-27
HUP0001069A2 (hu) 2000-10-28
EP0835880A1 (fr) 1998-04-15
BR9712306A (pt) 1999-08-31
SI9720063A (sl) 1999-08-31
KR20000048826A (ko) 2000-07-25
PL332774A1 (en) 1999-10-11
HUP0001069A3 (en) 2000-12-28
CA2266848A1 (fr) 1998-04-23
WO1998016558A1 (fr) 1998-04-23
RU2191032C2 (ru) 2002-10-20
ID21364A (id) 1999-05-27
NO991733D0 (no) 1999-04-13
AU725134B2 (en) 2000-10-05
SK46699A3 (en) 2000-06-12
CN1233258A (zh) 1999-10-27
NZ334885A (en) 2000-09-29
US6136312A (en) 2000-10-24
IL129383A0 (en) 2000-02-17
CZ125599A3 (cs) 1999-07-14
AU4449597A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
NO991733L (no) FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering
DE69312077D1 (de) Behandlung von autoimmun- und entzundungskrankheiten
DE69535243D1 (de) Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
ATE233738T1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
ATA29495A (de) Zusammensetzung und verfahren zur prävention und behandlung von entzündungen mit immunglobulin a
FI935585A0 (fi) Pyrrolopyrimidiner
DE69333626D1 (de) Verwendung von Adamantan Derivaten zur Herstellung eines Medikaments zur GLAUKOMBEHANDLUNG
DE59105609D1 (de) Verwendung von anti-TNF-Antikörpern als Arzneimittel bei der Behandlung von Ischämien und deren Folgen.
NO180474C (no) Fremgangsmåte for potensiering av den analgetiske effekt av curcuminoider
DK166763C (da) Immunoglobulin-g-holdig fraktion
ATE117900T1 (de) Verfahren zur herstellung nicht modifizierter intravenös verabreichbarer igm- und/oder iga- haltige immunglobulinpräparate.
DK0536182T3 (da) Fremgangsmåde til behandling af alopecia
ATE45961T1 (de) Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
DE69029858D1 (de) Behandlung von einer autoimmun-krankheit
ZA94333B (en) Synergistic combination of compound having an antogonist effect on NK1 and on NK2 receptors
ES2058343T3 (es) Piridinas disubstituidas.
DK0659082T3 (da) Anvendelse af cytochrom P450 inhibitorer til inhibering af metabolismen af nitrogensubstituerede acridiner
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
DE59106803D1 (de) Substituierte Pyrido-oxazine.
DE1792555A1 (de) Verfahren zur Herstellung von zur intravenoesen Anwendung geeignetem gamma-Globulin
ATE147269T1 (de) Behandlung von männerunfruchtbarkeit
PT65644B (de) Verfahren zur herstellung von 1,3-gleichsubstituierten triazin-2,4-dionen sowie deren verwendung als insektizide
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
EP0705110A4 (fr) Perfusion d'immunoglobulines dans des heterogreffes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application